137 results match your criteria Kugelberg Welander Spinal Muscular Atrophy


Monitoring Kidney Dysfunction in Kugelberg-Welander Syndrome.

Am J Case Rep 2019 Apr 3;20:441-446. Epub 2019 Apr 3.

Kidney Transplant Program, St. Michael's Hospital, Toronto, Canada.

BACKGROUND Kugelberg-Welander (K-W) syndrome is a type of spinal muscular atrophy that causes weakness of the hip-girdle muscles. If severe enough, this weakness can confine patients to a wheelchair in adult life. Proteinuria, a manifestation of kidney dysfunction, is associated with disorders of many organ systems. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12659/AJCR.914458DOI Listing
April 2019
2 Reads

Physical exercise training for type 3 spinal muscular atrophy.

Cochrane Database Syst Rev 2019 Mar 1;3:CD012120. Epub 2019 Mar 1.

Child Development and Exercise Center, Wilhelmina Children's Hospital, University Medical Center Utrecht, Lundlaan 6, Utrecht, Utrecht, Netherlands, 3508 AB.

Background: Physical exercise training might improve muscle and cardiorespiratory function in spinal muscular atrophy (SMA). Optimization of aerobic capacity or other resources in residual muscle tissue through exercise may counteract the muscle deterioration that occurs secondary to motor neuron loss and inactivity in SMA. There is currently no evidence synthesis available on physical exercise training in people with SMA type 3. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/14651858.CD012120.pub2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396106PMC
March 2019
3 Reads

Recent Advances and Clinical Applications of Exon Inclusion for Spinal Muscular Atrophy.

Methods Mol Biol 2018 ;1828:57-68

Department of Medical Genetics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.

Spinal muscular atrophy (SMA) is an autosomal recessive disorder caused by a mutation in SMN1 that stops production of SMN (survival of motor neuron) protein. Insufficient levels of SMN results in the loss of motor neurons, which causes muscle weakness, respiratory distress, and paralysis. A nearly identical gene (SMN2) contains a C-to-T transition which excludes exon 7 from 90% of the mature mRNA transcripts, leading to unstable proteins which are targeted for degradation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-8651-4_3DOI Listing
April 2019
22 Reads

Spinal muscular atrophy.

Handb Clin Neurol 2018 ;148:591-601

Neurogenetics Branch, National Institutes of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States. Electronic address:

Autosomal-recessive proximal spinal muscular atrophy (Werdnig-Hoffmann, Kugelberg-Welander) is caused by mutation of the SMN1 gene, and the clinical severity correlates with the number of copies of a nearly identical gene, SMN2. The SMN protein plays a critical role in spliceosome assembly and may have other cellular functions, such as mRNA transport. Cell culture and animal models have helped to define the disease mechanism and to identify targets for therapeutic intervention. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/B97804446407650
Publisher Site
http://dx.doi.org/10.1016/B978-0-444-64076-5.00038-7DOI Listing
August 2018
8 Reads

Cardiac pathology in spinal muscular atrophy: a systematic review.

Orphanet J Rare Dis 2017 04 11;12(1):67. Epub 2017 Apr 11.

Department of Neurology and Neurosurgery, F02.230, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Heidelberglaan 100, 3508 GA, Utrecht, The Netherlands.

Background: Hereditary proximal spinal muscular atrophy (SMA) is a severe neuromuscular disease of childhood caused by homozygous loss of function of the survival motor neuron (SMN) 1 gene. The presence of a second, nearly identical SMN gene (SMN2) in the human genome ensures production of residual levels of the ubiquitously expressed SMN protein. Alpha-motor neurons in the ventral horns of the spinal cord are most vulnerable to reduced SMN concentrations but the development or function of other tissues may also be affected, and cardiovascular abnormalities have frequently been reported both in patients and SMA mouse models. Read More

View Article

Download full-text PDF

Source
http://ojrd.biomedcentral.com/articles/10.1186/s13023-017-06
Publisher Site
http://dx.doi.org/10.1186/s13023-017-0613-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387385PMC
April 2017
6 Reads

Spinal muscular atrophies.

Authors:
Basil T Darras

Pediatr Clin North Am 2015 Jun 11;62(3):743-66. Epub 2015 Apr 11.

Division of Clinical Neurology, Department of Neurology, Boston Children's Hospital, 300 Longwood Avenue, Fegan 11, Boston, MA 02115, USA. Electronic address:

Spinal muscular atrophies (SMAs) are hereditary degenerative disorders of lower motor neurons associated with progressive muscle weakness and atrophy. Proximal 5q SMA is caused by decreased levels of the survival of motor neuron (SMN) protein and is the most common genetic cause of infant mortality. Its inheritance pattern is autosomal recessive, resulting from mutations involving the SMN1 gene on chromosome 5q13. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00313955150003
Publisher Site
http://dx.doi.org/10.1016/j.pcl.2015.03.010DOI Listing
June 2015
9 Reads

Anaesthesia and orphan disease: a patient with spinal muscular atrophy type III (Wohlfart-Kugelberg-Welander syndrome) undergoing laparoscopic cholecystectomy.

Eur J Anaesthesiol 2015 Mar;32(3):211-3

From the Department of Anesthesiology, Academic Medical Center (KEH), Department of Surgery (BJD), Department of Internal Medicine (MS), Department of Anaesthesiology, Slotervaart Hospital (AJP), Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/EJA.0000000000000145DOI Listing
March 2015
9 Reads

[General anesthetic management of a patient with spinal muscular atrophy type III].

Masui 2013 Jun;62(6):702-4

Department of Anesthesiology, Yao Municipal Hospital, Yao 581-0069.

We report a 61-year-old woman (weight 49 kg, height 156 cm) with Kugelberg-Welander disease who was scheduled for bilateral mastectomy under general anesthesia. We administered rocuronium 10 mg (0.20 mg x kg(-1)) for tracheal intubation. Read More

View Article

Download full-text PDF

Source
June 2013
6 Reads

Clinical and Genetic Study of Algerian Patients with Spinal Muscular Atrophy.

J Neurodegener Dis 2013 24;2013:903875. Epub 2013 Mar 24.

Service of Neurology CHU of Constantine, Algeria ; Laboratory of Biochemistry CHU of Constantine, Algeria.

Spinal muscular atrophy (SMA) is the second most common lethal autosomal recessive disorder. It is divided into the acute Werdnig-Hoffmann disease (type I), the intermediate form (type II), the Kugelberg-Welander disease (type III), and the adult form (type IV). The gene involved in all four forms of SMA, the so-called survival motor neuron (SMN) gene, is duplicated, with a telomeric (tel SMN or SMN1) and a centromeric copy (cent SMN or SMN2). Read More

View Article

Download full-text PDF

Source
http://downloads.hindawi.com/journals/jnd/2013/903875.pdf
Web Search
http://www.hindawi.com/journals/jnd/2013/903875/
Publisher Site
http://dx.doi.org/10.1155/2013/903875DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437343PMC
August 2015
3 Reads

[Two cases of Werdnig-Hofmann disease].

Rev Med Inst Mex Seguro Soc 2010 May-Jun;48(3):317-9

Instituto Mexicano del Seguro Social, Mexicali, Baja California, Mexico.

Spinal muscular atrophy (SMA) is an autonomic recessive disorder that affects the anterior horn cells of the spinal cord, degeneration of which results in proximal muscle weakness. It is classified into three types: I and II (Werdnig-Hoffmann disease) and III (Kugelberg-Welander disease). With an incidence of 1/10,000. Read More

View Article

Download full-text PDF

Source
February 2011
16 Reads

A humanized Smn gene containing the SMN2 nucleotide alteration in exon 7 mimics SMN2 splicing and the SMA disease phenotype.

Hum Mol Genet 2010 Nov 12;19(21):4239-52. Epub 2010 Aug 12.

Department of Pediatrics, The Research Institute at Nationwide Children's Hospital, Columbus, OH 43205, USA.

Proximal spinal muscular atrophy (SMA) is a neurodegenerative disease caused by low levels of the survival motor neuron (SMN) protein. In humans, SMN1 and SMN2 encode the SMN protein. In SMA patients, the SMN1 gene is lost and the remaining SMN2 gene only partially compensates. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/hmg/ddq343DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951869PMC
November 2010
7 Reads
9 Citations
6.393 Impact Factor

Malignant ventricular arrhythmia in a case of adult onset of spinal muscular atrophy (Kugelberg-Welander disease).

J Cardiovasc Electrophysiol 2009 Mar 13;20(3):342-4. Epub 2008 Oct 13.

Heart Rhythm Management Center, UZ Brussel, Vrije Universiteit Brussel, Brussels, Belgium.

We present a case of a 43-year-old male patient with adult onset of spinal muscular atrophy (SMA). The patient first came to our attention with atrioventricular (AV) block. A dual-chamber pacemaker (DDD-PM) was implanted. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1540-8167.2008.01327.xDOI Listing
March 2009
9 Reads

An autopsy case of spinal muscular atrophy type III (Kugelberg-Welander disease).

Neuropathology 2009 Feb 11;29(1):63-7. Epub 2008 Apr 11.

Department of Neurology, Suzuka National Hospital, Suzuka-shi, Mie, Japan.

We report an autopsy case of a 67-year-old man clinicogenetically diagnosed as having spinal muscular atrophy (SMA) type III (Kugelberg-Welander disease), showing slowly progressive muscle wasting and weakness of the extremities. His brother showed similar manifestations. Autopsy revealed neuronal loss and severe gliosis in the anterior horns of the spinal cord, a marked neurogenic change of skeletal muscles and mild degeneration of cardiomyocytes. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1440-1789.2008.00910.xDOI Listing
February 2009
9 Reads

[Anesthetic management of a patient with spinal muscular atrophy type III].

Masui 2008 Mar;57(3):358-9

Department of Anesthesiology, Fukuoka University School of Medicine, Fukuoka 814-0180.

We report a 38-year-old man with Kugelberg-Welander disease who underwent triple arthrodesis for talipes equinovarus under combined spinal-epidural anesthesia supplemented with continuous intravenous infusion of propofol. There was no ventilatory disturbance, muscle weakness, or neurologic untoward event during perioperative period. Read More

View Article

Download full-text PDF

Source
March 2008
5 Reads

Cardiac involvement in Kugelberg-Welander disease: a case report and review.

Am J Med Sci 2006 Dec;332(6):354-6

Division of Cardiovascular Medicine, Department of Internal Medicine, Shimane University School of Medicine, Izumo City, Shimane, Japan.

There are few reports of cardiac involvement in patients with Kugelberg-Welander disease. We report a case of a 51-year-old man with Kugelberg-Welander disease who presented with syncope. His electrocardiogram showed complete right bundle branch block and transient complete atrioventricular block without escape rhythm. Read More

View Article

Download full-text PDF

Source
December 2006
4 Reads

Atypical presentations of spinal muscular atrophy type III (Kugelberg-Welander disease).

Neuromuscul Disord 2006 Aug 22;16(8):492-4. Epub 2006 Jun 22.

Department of Neurology, Children's Hospital Boston and Harvard Medical School, Fegan 11, 300 Longwood Avenue, Boston, MA 02115, USA.

Spinal muscular atrophy type III (SMA III, Kugelberg-Welander disease) typically presents with symmetric proximal weakness, areflexia, and hypotonia. We present four children with spinal muscular atrophy type III who had atypical phenotypes. Three patients clearly had asymmetric weakness at presentation and two had upper motor neuron signs in the lower extremities (one patient had both features). Read More

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S096089660600133
Publisher Site
http://dx.doi.org/10.1016/j.nmd.2006.05.004DOI Listing
August 2006
5 Reads

Moraxella catarrhalis sepsis in a patient with juvenile spinal muscle atrophy.

Neth J Med 2005 Jun;63(6):227-9

Department of Intensive Care, Alkmaar Medical Centre, Alkmaar, The Netherlands.

Moraxella catarrhalis rarely causes severe infections or bacteraemia in healthy subjects. In the literature only four cases of clinical sepsis with M. catarrhalis have been described, mostly in immunocompromised patients. Read More

View Article

Download full-text PDF

Source
June 2005
4 Reads

[Neonatal muscular spinal atrophy: a case report].

Pediatr Med Chir 2004 Mar-Apr;26(2):139-41

Dipartimento di Pediatria,Azienda Gravina, Caltagirone (CT).

Spinal Muscular Atrophy (SMA) is an autosomal recessive disease characterized by diffuse proximal and distal weakness due to deletions of the survival motor neuron (SMN) gene localised on chromosome 5q13. Pathological studies show decreased numbers of motorneurons in spinal cord. SMA was initially sub-classified clinically into three types base on age at onset and clinical course. Read More

View Article

Download full-text PDF

Source
March 2005
6 Reads

Wolfhart Kugelberg Welander syndrome. 1974.

Can J Neurol Sci 2004 Nov;31(4):530-8

View Article

Download full-text PDF

Source
November 2004
13 Reads

Dilated cardiomyopathy in Kugelberg-Welander disease: coexisting sleep disordered breathing and its treatment with continuous positive airway pressure.

Intern Med 2004 Oct;43(10):951-4

Department of Internal Medicine, Suzuka National Hospital, 3-2-1 Kasado, Suzuka, Mie 513-8501.

A rare complication of possible secondary dilated cardiomyopathy to Kugelberg-Welander disease was described in a 53-year-old patient with this inherent motor neuron disease, whom we diagnosed after a genetic analysis of the defective survival motor neuron gene. An association of sleep disordered breathing of Cheyne-Stokes respiration was diagnosed, which was virtually eliminated with continuous positive airway pressure via nasal mask. Considering the paucity of therapeutic options in most degenerative neuromuscular disorders, ameliorations in not only sleep quality but also cardiac function with continuous positive airway pressure have clinical implications. Read More

View Article

Download full-text PDF

Source
October 2004
9 Reads

Anaesthesia for caesarean section in spinal muscular atrophy type III.

Int J Obstet Anesth 2004 Jul;13(3):192-5

Department of Anaesthesia, Essex Rivers Healthcare Trust, Colchester General Hospital, Colchester, UK.

We describe the conduct of general anaesthesia for a patient with spinal muscular atrophy Type III (Kugelberg-Welander disease) undergoing elective caesarean section. Apart from a delayed return of skeletal muscle power following non-depolarising neuromuscular blockade the procedure was uneventful. We found no previously published reports of general anaesthesia for caesarean section in this condition in the English language literature. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijoa.2004.01.006DOI Listing
July 2004
4 Reads

Anaesthesia for caesarean section in a patient with spinal muscular atrophy.

Authors:
A U Buettner

Anaesth Intensive Care 2003 Feb;31(1):92-4

Department of Anaesthesia, The Royal Women's Hospital, Melbourne, 132 Grattan Street, Carlton, Vic. 3053.

This report describes a 33-year-old primigravid woman with spinal muscular atrophy Type III (Kugelberg-Welander syndrome). Elective caesarean section was performed at 38 weeks gestation under spinal anaesthesia. The implications of spinal muscular atrophy for anaesthesia for caesarean section are described. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0310057X0303100118DOI Listing
February 2003
3 Reads

[Diagnostic progress in spinal muscular atrophy].

Przegl Lek 2001 ;58(11):989-91

Klinika Neurologii Dzieciecej Wydziału Lekarskiego Collegium Medicum Uniwersytetu Jagiellońskiego, ul. Wielicka 265, 30-663 Kraków.

Progress of diagnostic methods in recognition of spinal muscular atrophy (SMA), the most common degenerative disease of the nervous system in children has been observed in the last years. It has been proved, that all types of SMA, phenotypically variable Werdnig-Hoffman and Kugelberg-Welander diseases are results of homozygous absence of the telomeric copy of SMN gene located on the long arm of chromosome 5; this discovery was very important for mechanisms investigation. Based on the evolution of SMA diagnostic, the results of diagnostic in 18 children hospitalized in the Department of Pediatric Neurology Collegium Medicum of Jagiellonian University are presented. Read More

View Article

Download full-text PDF

Source
June 2002
3 Reads

Hodgkin's disease complicated by the nephrotic syndrome in a man with Kugelberg-Welander disease.

Leuk Lymphoma 2001 Jul;42(3):561-6

Division of Haematology and Medical Oncology, Peter MacCallum Cancer Institute, Melbourne, Victoria, Australia.

A case of nephrotic syndrome due to minimal change glomerulonephritis complicating Hodgkin's disease in a man with a longstanding neurological disorder is presented. Treatment with combination chemotherapy resulted in a rapid improvement in the nephrotic syndrome, and complete remission of the Hodgkin's disease. Disease relapse occurred less than 12 months later without recurrence of the nephrotic syndrome and was refractory to further treatment. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428190109064618DOI Listing
July 2001
3 Reads

Spinal muscular atrophy: present state.

Brain Pathol 2001 Apr;11(2):231-47

Department of Medical Physiology, University of Copenhagen, Denmark.

Spinal muscular atrophy (SMA) is a hereditary neurodegenerative disease caused by homozygous deletions or mutations in the SMN1 gene on Chr.5q13. SMA spans from severe Werdnig-Hoffmann disease (SMA 1) to relatively benign Kugelberg-Welander disease (SMA 3). Read More

View Article

Download full-text PDF

Source
April 2001
4 Reads

[Molecular basis of spinal muscular atrophy: th SMN gene].

Authors:
E Tizzano M Baiget

Neurologia 2000 Nov;15(9):393-400

Servicio de Genética, Hospital de la Santa Creu i Sant Pau, Barcelona.

Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disease characterized by degeneration and loss of motor neurons of the anterior horn of the spinal cord. The clinical manifestations include proximal symmetric weakness and progressive atrophy of muscle. SMA is classified by age of onset, severity of symptoms, and evolution in three groups: type I, severe or Werdnig-Hoffmann disease, type II or intermediate and type III, moderate-mild, Kugelberg-Welander disease. Read More

View Article

Download full-text PDF

Source
November 2000
4 Reads

[Wohlfart-Kugelberg-Welander disease (SMA type III)].

Authors:
Y Hirayama M Osawa

Ryoikibetsu Shokogun Shirizu 1999 (27 Pt 2):371-4

Department of Pediatrics, Tokyo Women's Medical University.

View Article

Download full-text PDF

Source
October 1999
4 Reads

Spinal muscular atrophy and Ehlers-Danlos syndrome : a rare association.

Neurol India 1997 Oct-Dec;45(4):271-272

Department of Neurology and Neurosurgery, Madurai Medical College and Govt. Rajiv Hospital, Madurai - 625 020, Tamilnadu, India.

Ehlers-Danlos Syndrome (EDS) is a group of heritable connective tissue disorders characterised by hyperelasticity of the skin and hypermobile joints. In addition to those features it is often associated with many systemic complications. Though many neurological complications have been described, an association of spinal muscular atrophy (SMA) has not been reported. Read More

View Article

Download full-text PDF

Source
March 2018
4 Reads

Correlation between severity and SMN protein level in spinal muscular atrophy.

Nat Genet 1997 Jul;16(3):265-9

Unité de Recherches sur les Handicaps Génétiques de L'Enfant, INSERM, Unité 393, IFREM, Institut Necker, Hôpital des Enfants Malades, Paris, France.

Spinal muscular atrophy (SMA) is a common autosomal recessive neuromuscular disorder characterized by degeneration of motor neurons of the spinal cord. Three different forms of childhood SMA have been recognized on the basis of age at onset and clinical course: Werdnig-Hoffmann disease (type-1), the intermediate form (type-II) and Kugelberg-Welander disease (type-III). A gene termed 'survival of motor neuron' (SMN) has been recognized as the disease-causing gene in SMA. Read More

View Article

Download full-text PDF

Source
http://www.nature.com/doifinder/10.1038/ng0797-265
Publisher Site
http://dx.doi.org/10.1038/ng0797-265DOI Listing
July 1997
6 Reads

Juvenile-onset spinal muscular atrophy caused by compound heterozygosity for mutations in the HEXA gene.

Ann Neurol 1997 May;41(5):631-8

Department of Human Genetics, Sackler Faculty of Medicine, Tel Aviv University, Israel.

Progressive proximal muscle weakness is present both in spinal muscular atrophy (SMA) type III (Kugelberg-Welander disease) and in GM2 gangliosidosis, diseases that segregate in an autosomal recessive fashion. The SMN gene for SMA and the HEXA gene for GM2 gangliosidosis were investigated in a woman with progressive proximal muscle weakness, long believed to be SMA type III (Kugelberg-Welander type). She and her family underwent biochemical studies for GM2 gangliosidosis. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ana.410410512
Publisher Site
http://dx.doi.org/10.1002/ana.410410512DOI Listing
May 1997
4 Reads

[Juvenile GM2 gangliosidosis with progressive spinal muscular atrophy onset].

Rev Neurol (Paris) 1997 Mar;153(2):120-3

Service de Neurologie, CHU Bicêtre, Le Kremlin-Bicêtre.

GM2 gangliosidosis are caused by a beta-hexosaminidase A enzyme deficiency. Mutations in the gene leaving residual enzyme activity give rise to juvenile and adult forms of the disease which have a great clinical heterogeneity. We report three cases which have been considered for some time as Kugelberg-Welander disease. Read More

View Article

Download full-text PDF

Source
March 1997
4 Reads

Differential diagnosis of limb girdle syndromes.

Electromyogr Clin Neurophysiol 1996 Dec;36(8):469-75

Department of Neurology, University Hospital Tzaritza Ioanna, Sofia.

The term limb girdle syndrome includes a variety of neuromuscular disorders like the scapulohumeral and pelvifemoral types of muscular dystrophy, quadriceps myopathy and Wohlfart-Kugelberg-Welander syndrome. There may be considerable difficulty in distinguishing between different types of limb girdle syndrome, even with the aid of electromyographic and muscle biopsy examinations. The aim of this investigation was to reestablish the clues for distinguishing between different types of limb girdle syndrome. Read More

View Article

Download full-text PDF

Source
December 1996
5 Reads

Spinal muscular atrophy type II (intermediary) and III (Kugelberg-Welander). Evolution of 50 patients with physiotherapy and hydrotherapy in a swimming pool.

Arq Neuropsiquiatr 1996 Sep;54(3):402-6

Universidade Federal de São Paulo--Escola Paulista de Medicina (UNIFESP-EPM), Brasil.

We added hydrotherapy to 50 patients with spinal muscular atrophy (SMA) who were being treated with individual conventional physiotherapy. Hydrotherapy performed at an approximate temperature of 30 degrees Celsius, twice a week, for thirty minutes in children and forty-five minutes in adults during a 2-year period. The outcome derived from this combined modality of treatment was rated according to physiotherapeutic evaluations, the MMT (Manual Muscular Test), and the Barthel Ladder. Read More

View Article

Download full-text PDF

Source
September 1996
10 Reads

[Molecular genetic diagnosis and deletion analysis in Type I-III spinal muscular atrophy].

Schweiz Med Wochenschr 1996 May;126(21):907-14

Institut für Medizinische Genetik, Universität Zürich.

Autosomal recessive spinal muscular atrophy (SMA) is, after cystic fibrosis, the second most common fatal monogenic disorder. The disease is characterized by degeneration of anterior horn cells leading to progressive paralysis with muscular atrophy. Depending on the clinical type (Werdnig-Hoffmann = type I, intermediate form = type II, Kugelberg-Welander = type III), SMA causes early death or increasing disability in childhood. Read More

View Article

Download full-text PDF

Source
May 1996
6 Reads

[Cardiac involvement in Kugelberg-Welander disease. A prospective study of 8 cases].

Arch Mal Coeur Vaiss 1996 May;89(5):611-7

Service de cardiologie infantile, Hôpital Roger Salengro, CHRU de Lille.

Kugelberg-Welander disease is a juvenile form of slowly progressive spiral amyotrophy in which the incidence of cardiac involvement is difficult to appreciate as cases are sporadic. Classically, it presents with atrial hyperexcitability with variable degrees of atrioventricular block. In order to assess the prevalence of cardiac involvement in this condition, the authors undertook a prospective study in 8 patients with Kugelberg-Welander disease. Read More

View Article

Download full-text PDF

Source
May 1996
3 Reads

Large scale deletions of the 5q13 region are specific to Werdnig-Hoffmann disease.

J Med Genet 1996 Apr;33(4):281-3

Unité de Recherches sur les Handicaps Génétiques de l'Enfant, INSERM U-393, IFREM, Institut Necker, Hôpital des Enfants-Malades, Paris, France.

Spinal muscular atrophy (SMA) is characterised by degeneration of anterior horn cells of the spinal cord and represents the second most common, lethal, autosomal recessive disorder after cystic fibrosis. Based on the criteria of the Internatinal SMA Consortium, childhood SMAs are classified into type I (Werdnig-Hoffmann disease), type II (intermediate form), and type III (Kugelberg-Welander disease). Recently, two genes have been found to be associated with SMA. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1050575PMC
April 1996
5 Reads

Emergency intubation through the laryngeal mask airway. The effective application of cricoid pressure.

Anaesthesia 1994 Aug;49(8):696-7

Department of Anaesthesia, Frenchay Hospital, Bristol.

A patient with Kugelberg-Welander disease presented as an unexpected difficult intubation. Tracheal intubation was achieved through the laryngeal mask airway, while regurgitation was prevented with continuous cricoid pressure. Regurgitation occurred after cricoid pressure was released. Read More

View Article

Download full-text PDF

Source
August 1994
3 Reads

[Heart involvement in progressive spinal muscular atrophy. A review of the literature and case histories in childhood].

Pediatr Med Chir 1994 Mar-Apr;16(2):125-8

Cattedra di Neonatologia e Servizio Autonomo di Cardiologia Pediatrica, Università di Catania, Italia.

There are few cardiological studies in progressive spinal muscular atrophy and mainly concern subjects affected by the juvenile form (Kugelberg-Welander disease). The presence of a cardiomyopathy has been reported in these patients but the cardiac involvement is often secondary to the chronic respiratory insufficiency typical of the disease. We performed a retrospective study in our Institute on 43 patients, age range 3 months to 3 years, 37 of which presented type I (Werdnig-Hoffmann disease) and 6 type II (intermediate form) of the disease. Read More

View Article

Download full-text PDF

Source
October 1994
2 Reads

The use of chromosome 5q markers for confirming the diagnosis of proximal spinal muscular atrophy.

Braz J Med Biol Res 1993 Nov;26(11):1157-73

Departamento de Bioquímica, Universidade de São Paulo, Brasil.

1. Five Brazilian families referred to us with a probable diagnosis of chronic proximal spinal muscular atrophy (Kugelberg-Welander) were identified, and permanent (Epstein Barr virus transformed) cell lines were established from members of four of the families. 2. Read More

View Article

Download full-text PDF

Source
November 1993
3 Reads

Assessment of nonallelic genetic heterogeneity of chronic (type II and III) spinal muscular atrophy.

Hum Hered 1993 Nov-Dec;43(6):380-7

Department of Psychiatry, Columbia University, College of Physicians and Surgeons, New York, NY 10032.

We have previously reported the mapping of the chronic (type II/intermediate and type III/mild/Kugelberg-Welander) form of the childhood-onset spinal muscular atrophies (SMA) to chromosome 5q11.2-13.3, with evidence for nonallelic genetic heterogeneity within a small sample of seven families [Brzustowicz et al. Read More

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/154164
Publisher Site
http://dx.doi.org/10.1159/000154164DOI Listing
February 1994
3 Reads

Pathological case of the month. Type 3 spinal muscular atrophy (Kugelberg-Welander disease).

Am J Dis Child 1993 Jul;147(7):793-4

Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison.

View Article

Download full-text PDF

Source
July 1993
5 Reads

Advanced EMG techniques in diagnostics of spinal muscular atrophies and motor neuron disease--magnetic stimulation, single fiber EMG and macro EMG.

Acta Univ Palacki Olomuc Fac Med 1993 ;136:37-9

EMG Laboratory, Clinic of Neurology, Medical Faculty, Palacký University, Olomouc, Czech Republic.

Motor neuron disease (MND) and spinal muscular atrophies (SMA) are difficult to diagnose with classical EMG methods because significant findings appear relatively late and both groups of diseases show neurogenic type of record differing only in a relatively greater amount of fasciculations and higher amplitude of motor unit potential (MUP) in MND compared with SMA. We examined 12 patients with MND-amyotrophic lateral sclerosis and 7 patients with SMA type III and IV according to Swash with advanced EMG techniques-magnetic stimulation, single fiber and macro EMG. With transcranial magnetic stimulation, a significant prolongation of cortical latency was found in MND (P < 0. Read More

View Article

Download full-text PDF

Source
April 1995
5 Reads

[A case of progressive bulbar paralysis in a child (Fazio-Londe disease)].

Neurol Neurochir Pol 1992 Sep-Oct;26(5):723-8

Kliniki Neurologicznej AM, Białymstoku.

The reported case was diagnosed in a girl aged 14, in whom the first signs developed at the age of 6, with progressive involvement of the cranial nerves IX, X, XI and XII, and V with VII. After ruling out other possible causes the diagnosis of the Fazio-Londe disease was established. Electromyographic examination confirming the diagnosis demonstrated also evidence of changes of neurogenic type in the muscles of upper extremities despite absence of demonstrable clinical abnormalities, which, as suggest the authors, may support the hypothesis of the similarity of the disease to other forms of spinal muscular atrophy, such as Werdnig-Hoffman and Kugelberg-Welander diseases. Read More

View Article

Download full-text PDF

Source
March 1993
2 Reads

[Clinical and histochemical findings in spinal muscular atrophy].

No To Shinkei 1992 Jun;44(6):547-52

Department of Neurology, National Minamikyusyu Hospital, Kagoshima, Japan.

The childhood form of the spinal muscular atrophy (SMA) is classically subdivided into three groups on the basis of a combination of age of onset, milestones of development and age of survival: acute Werdning-Hoffmann (type I), intermediate Werdnig-Hoffmann (type II) and Kugelberg-Welander disease (type III). Now we examined 7 cases of type I and 9 cases of type II on clinical and histochemical ground. Of the total of 16 cases, 5 cases had a family history of the disease. Read More

View Article

Download full-text PDF

Source
June 1992
2 Reads

Wohlfart-Kugelberg-Welander syndrome: serum creatine kinase and functional outcome.

Arch Phys Med Rehabil 1991 Jul;72(8):587-91

Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN 55905.

The medical records of 31 patients (19 male and 12 female) with clinical and electrophysiologic features of Wohlfart-Kugelberg-Welander syndrome were reviewed. The reported age at onset ranged from less than one year to 46 years, and the age at diagnosis ranged from three to 66 years. Proximal muscle weakness, especially of the lower extremities, and muscular atrophy were the predominant clinical features. Read More

View Article

Download full-text PDF

Source
July 1991
2 Reads